SCHEMBL25970514

SCHEMBL25970514

CN(Cc1ccccc1)[C@@H](C1CCCCC1)C1(O)CCCC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.44
SLC18A3 Q16572 3/20 0.43
LMNA P02545 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
CHRM2 P08172 1/20 0.39
CHRM1 P11229 1/20 0.39
CHRM3 P20309 1/20 0.39
SLC6A2 P23975 2/20 0.39
SLC6A4 P31645 2/20 0.39
ADRA2B P18089 1/20 0.39
ADRA2C P18825 1/20 0.39
HTR2A P28223 1/20 0.39
ADRA1A P35348 1/20 0.39
OPRK1 P41145 1/20 0.39
SLC6A3 Q01959 1/20 0.39
KCNH2 Q12809 1/20 0.39
ACHE P22303 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17138280 0.73 SLC18A3 (0.48) L3MBTL1SLC18A3MEN1KMT2ASLC6A2
SCHEMBL17138281 0.73 SLC18A3 (0.48) L3MBTL1SLC18A3MEN1KMT2ASLC6A2
SCHEMBL17138261 0.71 L3MBTL1 (0.51) L3MBTL1SLC18A3MEN1KMT2ASLC6A2
SCHEMBL25663657 0.71 SLC6A2 (0.40) LMNAMEN1KMT2ACHRM2CHRM1
SCHEMBL25663636 0.69 SIGMAR1 (0.40) LMNAMEN1KMT2ACHRM2CHRM1
SCHEMBL17138274 0.69 L3MBTL1 (0.45) L3MBTL1SLC18A3MEN1KMT2ASLC6A2
SCHEMBL17138272 0.69 L3MBTL1 (0.45) L3MBTL1SLC18A3MEN1KMT2ASLC6A2
SCHEMBL17138279 0.68 L3MBTL1 (0.44) L3MBTL1SLC18A3MEN1KMT2ASLC6A2
SCHEMBL18079511 0.67 L3MBTL1 (0.46) L3MBTL1SLC18A3MEN1KMT2ASLC6A2
SCHEMBL14492358 0.67 SLC6A2 (0.56) L3MBTL1SLC18A3MEN1KMT2ASLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11718638-B2 Compounds, compositions and methods for synthesis WAVE LIFE SCIENCES LTD. (SG) 2023-08-08 US disclosed
US-11718638-B2 Compounds, compositions and methods for synthesis WAVE LIFE SCIENCES LTD. (SG) 2023-08-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11718638-B2 Compounds, compositions and methods for synthesis ALKBH1, DUT, RNGTT L3MBTL1 1497/4885SLC18A3 2260/4885LMNA 434/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.